301 related articles for article (PubMed ID: 25742518)
1. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
Legler J; Fletcher T; Govarts E; Porta M; Blumberg B; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1278-88. PubMed ID: 25742518
[TBL] [Abstract][Full Text] [Related]
2. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
Gore AC; Chappell VA; Fenton SE; Flaws JA; Nadal A; Prins GS; Toppari J; Zoeller RT
Endocr Rev; 2015 Dec; 36(6):E1-E150. PubMed ID: 26544531
[TBL] [Abstract][Full Text] [Related]
3. Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
Gore AC; Chappell VA; Fenton SE; Flaws JA; Nadal A; Prins GS; Toppari J; Zoeller RT
Endocr Rev; 2015 Dec; 36(6):593-602. PubMed ID: 26414233
[TBL] [Abstract][Full Text] [Related]
4. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment.
Braun JM
Nat Rev Endocrinol; 2017 Mar; 13(3):161-173. PubMed ID: 27857130
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Syndrome and Endocrine Disrupting Chemicals: An Overview of Exposure and Health Effects.
Haverinen E; Fernandez MF; Mustieles V; Tolonen H
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948652
[TBL] [Abstract][Full Text] [Related]
6. Prioritizing Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using ToxCast™ High-Throughput Data.
Auerbach S; Filer D; Reif D; Walker V; Holloway AC; Schlezinger J; Srinivasan S; Svoboda D; Judson R; Bucher JR; Thayer KA
Environ Health Perspect; 2016 Aug; 124(8):1141-54. PubMed ID: 26978842
[TBL] [Abstract][Full Text] [Related]
7. Endocrine-disrupting chemicals: economic, regulatory, and policy implications.
Kassotis CD; Vandenberg LN; Demeneix BA; Porta M; Slama R; Trasande L
Lancet Diabetes Endocrinol; 2020 Aug; 8(8):719-730. PubMed ID: 32707119
[TBL] [Abstract][Full Text] [Related]
8. Hormonal Injustice: Environmental Toxicants as Drivers of Endocrine Health Disparities.
Weiss MC; Wang L; Sargis RM
Endocrinol Metab Clin North Am; 2023 Dec; 52(4):719-736. PubMed ID: 37865484
[TBL] [Abstract][Full Text] [Related]
9. Endocrine-disrupting chemicals: Mainstream recognition of health effects and implications for the practicing internist.
Trasande L; Sargis RM
J Intern Med; 2024 Feb; 295(2):259-274. PubMed ID: 38037246
[TBL] [Abstract][Full Text] [Related]
10. The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds.
Legler J; Zalko D; Jourdan F; Jacobs M; Fromenty B; Balaguer P; Bourguet W; Munic Kos V; Nadal A; Beausoleil C; Cristobal S; Remy S; Ermler S; Margiotta-Casaluci L; Griffin JL; Blumberg B; Chesné C; Hoffmann S; Andersson PL; Kamstra JH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423144
[TBL] [Abstract][Full Text] [Related]
11. A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters".
Rhomberg LR; Goodman JE; Foster WG; Borgert CJ; Van Der Kraak G
Crit Rev Toxicol; 2012 Jul; 42(6):465-73. PubMed ID: 22630047
[TBL] [Abstract][Full Text] [Related]
12. Chemicals Used in Plastic Materials: An Estimate of the Attributable Disease Burden and Costs in the United States.
Trasande L; Krithivasan R; Park K; Obsekov V; Belliveau M
J Endocr Soc; 2024 Jan; 8(2):bvad163. PubMed ID: 38213907
[TBL] [Abstract][Full Text] [Related]
13. Transgenerational effects of obesogens and the obesity epidemic.
Chamorro-García R; Blumberg B
Curr Opin Pharmacol; 2014 Dec; 19():153-8. PubMed ID: 25460228
[TBL] [Abstract][Full Text] [Related]
14. Comparing cost-of-illness estimates from alternative approaches: an application to diabetes.
Honeycutt AA; Segel JE; Hoerger TJ; Finkelstein EA
Health Serv Res; 2009 Feb; 44(1):303-20. PubMed ID: 19146569
[TBL] [Abstract][Full Text] [Related]
15. Wildlife, human and environmental costs of using lead ammunition: An economic review and analysis.
Pain DJ; Dickie I; Green RE; Kanstrup N; Cromie R
Ambio; 2019 Sep; 48(9):969-988. PubMed ID: 30879269
[TBL] [Abstract][Full Text] [Related]
16. Childhood obesity and environmental chemicals.
La Merrill M; Birnbaum LS
Mt Sinai J Med; 2011; 78(1):22-48. PubMed ID: 21259261
[TBL] [Abstract][Full Text] [Related]
17. The perfect storm for obesity.
Heindel JJ; Schug TT
Obesity (Silver Spring); 2013 Jun; 21(6):1079-80. PubMed ID: 23784921
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Obesogens in the XXI century: emerging health challenges volume II.
Sousa ACA; Malarvannan G; Isobe T; Rato L
Front Endocrinol (Lausanne); 2023; 14():1292334. PubMed ID: 37867505
[No Abstract] [Full Text] [Related]
19. High costs of cardiovascular disease in the European Union.
Weintraub WS
Eur Heart J; 2023 Dec; 44(45):4768-4770. PubMed ID: 37632364
[No Abstract] [Full Text] [Related]
20. Plastic related chemicals: Disease burden and costs in the United States.
Lillehei A
Explore (NY); 2024; 20(3):277-278. PubMed ID: 38453553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
